Good MorningThe major indices jumped more than 1.0% as investors looked to the midterm elections and the changes they may bring. By the end of the day today, certainly by the opening of trading on Wednesday, the market will know if Republicans have taken control of Capital Hill or if the Democrats and the Biden Agenda have won out. Either way, the news will move markets on Wednesday and could impact the market's direction well into 2023.
The biggest risk this week is, however, the CPI reading which is due out on Thursday. The consumer level inflation is expected to remain hot on all levels but may show some slowing in the YOY comparisons if not enough to alter the Fed's stance on interest rates. The question that needs to be answered, however, is if the FOMC will hike by another 75 bps in December or if this data will give them the room to start slowing the pace of interest rate increases. Featured: I've seen this movie before (last time: 17,556%) (Ad) 
|
Technology | |
Twilio, Inc. (NYSE: TWLO) stock slipped 25.1% in premarket action, last week, after posting sales numbers that were weaker than expected. All of this despite the fact the cloud-based communications software firm also posted revenue is up 33% over the last 12 months, to $983 million beating analyst... Read the Full Story |
|
From Our Partners | | One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday.
That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves.
Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts. | | Watch the free presentation to see how the payouts work |
|
Consumer Discretionary | |
Sometimes the hunted become the hunters.
Back in 2018, traditional automakers like Ford, Chevrolet, and Toyota made more money than anyone selling electric vehicles in the United States. Then Tesla burst onto the scene.
With Tesla all-in on EVs and the old guys making a mix of gas guzzlers and E... Read the Full Story |
|
Consumer Discretionary | |
Apparel manufacturer V.F. Corporation (NYSE: VFC) may as well stand for Very Fragile Corporation.
Its stock is down more than 60% thus far in 2022 and trading at an 11-year low. Industry peers like Under Armour and HanesBrands have had similarly rough years but they at least performed well in 20... Read the Full Story |
|
From Our Partners | | A decade of trading taught one investor that predicting the market isn't enough. That lesson helped grow a portfolio to $800,000 using a single ironclad principle.
That principle, and why it matters more than any prediction, is detailed in the free report The Only TRUE Options Edge. | | Download the free report to rethink your options trading strategy today. |
|
Markets | |
Last summer, Skechers U.S.A., Inc. (NYSE: SKX) was reopening stores, launching new products and expanding overseas. Growth investors loved the results and the stock ran above $50.
It’s been a steady downhill jog ever since for the sneaker retailer.
Skechers recently posted another disappoi... Read the Full Story |
|
Consumer Discretionary | |
If you are wondering why Mullen Automotive’s share prices are in the tank after rising meteorically in October it is because of the short interest. The shorts were taken by surprise when the stock jumped from $0.20 to $0.60 but they were not sent packing. No, they do not believe in this stoc... Read the Full Story |
|
From Our Partners | | BlackRock's new fund hit $2.8 billion in under three months. JPMorgan is now running $2 billion a day through the same infrastructure, while Vanguard and State Street race to catch up.
A BNY Mellon survey found 97% of institutional investors believe this shift will revolutionize asset management. Larry Fink calls it the next major evolution in market infrastructure, with as much as $382 trillion potentially flowing onto these rails over the next year. | | Get the free report naming the asset institutions are quietly accumulating. |
|
Technology | |
Palantir (NYSE: PLTR) is not precisely a “deep-value stock” relative to its price-to-earnings multiple but value is, as they say, where you find it. The stock is trading at a whopping high 165X its current-year earrings compared to much lower valuations for the broad S&P 500 and ev... Read the Full Story |
|
Technology | | Santa Clara-based best-in-class computer networking company Arista Networks (NASDAQ: ANET) supplies multilayer network switches delivering software-defined networking (SDN) solutions to data centers and information technology customers. It’s switches are used for cloud and high-performance com... Read the Full Story |
|
Consumer Discretionary | |
Even a perennial outperformer like Amazon.com (NASDAQ: AMZN) takes its lumps once in a while. After finishing higher in each of the last seven years, the company is on pace to lose roughly half its market value in 2022.
Common culprits like supply chain disruption and higher labor costs have bee... Read the Full Story |
|
Consumer Discretionary | | Global coffee products retailer Starbucks (NYSE: SBUX) stock has evolved beyond just coffeeshops as it has expanded to include brands like Teavana, Ethos, Princi, Seattle’s Best Coffee, Evolution Fresh, and Starbucks Reserve under its umbrella. Starbucks has established its brand as a premium ... Read the Full Story |
|
Consumer Discretionary | | How to invest in blue chip stocks, exactly? The short answer: carefully, just like with any other investment. Investing in blue-chip stocks depends on your preferences, risk tolerance, portfolio objectives and diversification. When investing in blue chips, it's important to make the right choices.... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. | | View Today's Stock Pick |
|
